Transient amaurosis in patient with pituitary macroadenoma after intravenous gonadotropin and thyrotropin releasing hormones.
D000236:Adenoma / Q000150:complications*; D001766:Blindness / Q000139:chemically induced*; D006065:Gonadotropins, Pituitary / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications*; D013973:Thyrotropin-Releasing Hormone / Q000009:adverse effects*
D006065:Gonadotropins, Pituitary; D013973:Thyrotropin-Releasing Hormone